Perfluoroalkyl compounds (PFCs) are a class of organic molecules used in industry and consumer products. PFCs are non-biodegradable and bioaccumulate in the environment and for these reasons they have been a major subject of research regarding their toxicity, environmental fate, and sources of human exposure, since they have been shown to induce severe health consequences, such as neonatal mortality, neurotoxicity and immunotoxicity. The aim of this review is to explore the existing knowledge of the interplay between PFCs exposure and human health, with a focus on male reproductive health, given the emerging gender differences in PFCs clearance and their interaction with sex hormones receptors. A comprehensive PUBMED search was performed using relevant key terms for PFCs and male fertility. Different degrees of evidence suggest an impairment of semen parameters and sex hormones in relation to PFCs exposure. These preliminary results point towards a sex-dependent pharmacodynamics and clearance, with males having a much higher tendency to accumulation. Moreover, because of the widespread environmental occurrence of these chemicals, along with their ability to cross the placental barrier, exposure of the foetus to these compounds is inevitable. This is of concern because foetal development of the male reproductive organs may be disturbed by exposure to exogenous factors. These findings clearly suggest an antiandrogenic potential of PFCs and a link between endocrine disruptors and disorders of male health.
Perfluoroalkyl compounds and human health
Perfluoroalkyl compounds (PFCs) are a class of organic molecules characterized by fluorinated hydrocarbon chains extensively used in industry and consumer products including oil and water repellents, coatings for cookware, carpets and textiles. PFCs possess unique physical chemical properties due to their amphiphilic structures and their strong carbonfluorine bonds. Their chemical and thermal stability are mainly due to the strong C-F bonds, making them nonreactive. Therefore, long chain PFCs are non-biodegradable and bioaccumulate in the environment [1, 2] . PFCs have been found in humans and in the global environment and their toxicity, environmental fate, and sources of human exposure have been a major subject of research (Supplemental Fig. 1 ). Currently, 23 PFCs are available, which includes perfluorooctanoic acid (PFOA) and perfluooctane sulfonate (PFOS), which are the predominant forms in human and environmental samples. However, the stability that makes PFCs desirable for commercial use, also entails that they are environmental contaminants due to their resistance to various modes of degradation [3] . They circulate bound to albumin in the serum [4] , making their detection easier in human blood as an indication of long-term exposure [5] . Various PFCs compounds have been found in human serum [6] , seminal fluid [7] , breast milk [8] and even umbilical cord [9] , suggesting a life-long exposure to PFCs in humans, from foetal stages until the adult life. In addition, some PFCs have been detected in tissues of the lung, thyroid, gonads, adipose tissue, pancreas, skeletal muscles and brain [10] [11] [12] [13] . In addition to their persistence, PFOA and PFOS have been shown to induce severe health consequences, such as neonatal mortality, neurotoxicity and immunotoxicity: PFCs act as endocrine disruptors on the foetus and newborns, leading to developmental defects [14] . Indeed they have been shown to act as estrogenic-like molecules by interfering on thyroid and sexual hormones signalling [15] . This has led to the strict regulation of PFOA and PFOS use in industrial processes, as the compounds were added to the Annex B of the Stockholm Convention on Persistent Organic Pollutants.
Perfluoroalkyl compounds in human fertility
In addition to health concerns on the impact of these substances on foetal development, epidemiological studies have focused also on the relationship between PFCs and human fertility, but recent research has focused mostly on female fecundity. However, both in vitro and animal studies on PFCs toxicity have shown a detrimental effect of PFOA and PFOS on testicular function, by the alteration of steroidogenic machinery and subsequent defect of spermatogenesis [16] [17] [18] [19] [20] . Despite strong evidence pointing towards a negative role of PFCs on male reproductive function, to date few evidence are available on the actual effect of these substances on seminal parameters in men, with conflicting results [7, [21] [22] [23] [24] (Table 1) . Two cross-sectional studies reported negative associations of PFOS, or high PFOA and PFOS combined, with the proportion of morphologically normal spermatozoa in adult men [21, 25] . Furthermore, in a study of men attending an in vitro fertilization clinic, Raymer et al. [7] reported that luteinizing hormone (LH) and free testosterone were significantly positively correlated with plasma PFOA, although PFOA was not associated with semen characteristics. Conflicting results are reported also for the association between PFCs and sperm DNA quality, although a significant trend is evident for increased DNA fragmentation in exposed men [23, 24, 26] .
Among the endocrine effects of PFOS in particular, it should be emphasized that this compound can affect the hypothalamic-pituitary axis activity [27] [28] [29] . It is also able to exert its toxicity at testicular level [30] , as reported in rats [27, 28, 31] and in testis models [32] . According to a recent study on male rats [33] , high doses of PFOS orally administered for 28 days seem to modify the relative gene and protein receptor expressions of several hormones of the reproductive axis (GnRH, LH, FSH and testosterone). In humans, in utero exposure to PFOA was associated later in adult life with lower sperm concentration and total sperm count and with higher levels of luteinizing hormone and follicle-stimulating hormone [34] .
Effect of perfluoroalkyl compounds on male sex hormones
In infertile males, PFOS levels were higher than fertile counterparts, together with a higher gene expressions of estrogen receptor (ER) α, ERβ and androgen receptor (AR) [35, 36] , suggesting that PFCs activity might be linked also to the genetic expression of sex hormones nuclear receptors.
With respect to Androgen Receptor (AR), PFOS and PFOA induce a decrease of the protein expression of this receptor in the hypothalamus and pituitary gland as well as in the testis. This inhibition suggests that PFOS would affect the post-transcriptional processes of the AR synthesis. ARdependent gene expression is indeed crucial for male sexual differentiation in utero and male reproductive function and development, including spermatogenesis [37, 38] (Fig. 1) .
Three PFCs compounds (PFHxS, PFOS, and PFOA) were shown to act as ER agonists in vitro, and five PFCs (PFHxS, PFOS, PFOA, PFNA, and PFDA) acted as AR antagonists. The combined action of PFCs mixture showed a more than additive (synergistic) impact on AR function, compared with the AR-antagonizing effect concentrations of the single compounds [39] . These findings clearly suggest an antiandrogenic potential of PFCs and given the growing evidence suggesting a link between AR disruptors and disorders of male health [40, 41] (Table 1) , PFCs effect on AR and consequent derangement of hypothalamic-pituitary axis should be a major concern (Fig. 1) . These data lay the ground for future research based on PFCs-AR interaction, but the main question is how PFCs can cross the blood-testis barrier (BTB). It is known that PFOS has the ability to cross the blood brain barrier [42] and the placenta [9] , although the exact mechanism needs to be elucidated yet. This aspect is of particular importance, since PFOS were shown to alterate the Sertoli cell tight junction-permeability barrier, which ultimately changes destabilized Sertoli cell BTB integrity. These findings suggest that human exposure to PFCs might induce BTB dysfunction and infertility [43] .
Gender differences in pharmacokinetics of perfluoroalkyl compounds
The emerging evidence clearly shows the need for further research on the effect of PFCs on male fertility. The underestimation of the matter becomes even more pronounced if we take into consideration gender differences in PFCs accumulation in the organism. Indeed PFCs pharmacokinetics and tissue distribution have been recently studied in relation to gender [44] . However, most PFC toxicity and pharmacokinetics studies have been done in animals, mainly in rodents [45] [46] [47] [48] [49] (Table 2 ). In particular, in females PFCs showed a Significant increase in alterations of sperm parameters in PFC-positive subjects; disomy and diploidy rates were significantly increased in PFC-positive males; sperm DNA fragmentation index resulted significantly increased in PFC-positive subjects much shorter half-life, which is estimated between 2 and 4 h, compared with PFCs half-life in male, which is about 6 days [50] . Concomitantly, in females 60% of PFOA is cleared in urine or faeces within 24 h from ingestion, whereas in males only 9% of PFOA is removed within 12 days [51] . In humans, the half-life of PFCs is much longer than in animal models (e.g. 3-4 years for PFOA and 8-11 years for PFOS) [52, 53] , but data on human gender differences in PFCs pharmacokinetics are sparse (Table 2) . Half-lives for PFOA were estimated in 3.8 after 5 years of follow up in a subpopulation of former employees of a manufacturing facility that produced PFOA [54] . Similar values (3.26 years) were obtained in a different population of exposed residents [55] , after charcoal filtration was installed in the community water system. Finally, slightly lower half-life (2.3 years) was estimated in a study of residents living near a PFOA facility, [32] but after a relatively short follow-up period (1 year) [56] . Preliminary results indicate that a traditional exponential decay model is sufficient to describe the clearance of PFOA from the body, despite earlier indications that clearance may occur in a time-dependent fashion in animals [57] . The positive correlation between serum PFCs levels and the service length of occupational workers indicates the prevailing role of the exposure time in the serum PFCs concentrations. Urinary excretion is one of the primary clearance routes in rats for both PFOA and PFOS [58] and the important role of renal clearance (Cl renal ) in human excretion was widely proposed [32, 59] (Fig. 1) . The calculated Cl renal values for PFHxS, PFOA, PFOS ranged from 2.0 × 10 −4 to 2.3, 9.0 × 10 −5 to 2.4, and 5.0 × 10 −5 to 0.54 mL day −1 kg −1 with median values of 0.023, 0.067 and 0.010 mL day −1 kg −1 , respectively. In a recent study [60] , significant differences were not found in the daily renal clearance of PFOA and PFHxS between men and women, whereas the Cl renal values of PFOS were significantly lower in male workers than in females. Notably, considering menstrual bleeding as an alternative elimination route, the total clearance of PFHxS, PFOA and PFOS significantly differed between sexes [60] (Fig. 1) . The reported average menstrual clearance rate of 0.029 mL day −1 kg −1 in young females [61] and the daily renal clearance rates of the PFCs (0.024, 0.062 and 0.017 mL day −1 kg −1 for PFHxS, PFOA, and PFOS, respectively) showed indeed the same order of magnitude.
The mean values of the half-lives of PFHxS, PFOA, and PFOS for men here were 19.9, 4.7, and 60.9 years, respectively, while those for women were 7.5, 3.1, and 8.0 years, respectively.
Role of organic anion-transporting peptides
These preliminary results point towards a sex-dependent pharmacodynamics and clearance, with males having a much higher tendency to accumulation (Table 2 ; Fig. 1 ). These gender differences have been ascribed to Organic Anion-Transporting Peptides (OATPs), which are membrane transport proteins that mediate the transport of organic anions across the cell membrane, involved in PFCs renal uptake [48, 62] . Importantly, OATPs are steroid-dependent transporters [63] , which could explain the sex differences in PFCs accumulation. Indeed experimental studies on rodents have shown an enhanced renal clearance in orchidectomized rats, which is counteracted by testosterone administration [63] .
Because of the widespread environmental occurrence of PFOA and PFOS (Supplemental Fig. 1 ), along with their ability to cross the placental barrier [64, 65] , exposure of the developing human foetus to these compounds is inevitable (Fig. 1) . However, PFCs toxicity is not a concern only for the developing embryo, but also during adult life [66] : the presence of these chemicals in seminal fluid [7] suggests either a prostatic or testicular origin of PFCs. Despite the aforementioned role of OATPs in PFCs trafficking and gender-specific clearance, whether they are involved or not also in testicular or prostatic accumulation has not been elucidated yet, although their expression was confirmed in human testis and prostate (Reviewed in [67] ) (Fig. 1) . In the light of this evidence, future research should point towards the understanding of the role of PFCs in testis and prostate cancer. In contrast with animal studies, only testicular cancer has been associated with PFOA exposure in exposed human populations [68, 69] , but a weak, although non-significant, association with plasma PFOS concentration was found for incident prostate cancer [70] . Although the molecular mechanism of tumorigenesis might be mediated by PFCs interaction with PPARα [71] (Fig. 1) , the mechanism by which PFCs cross the testis barrier are not described. For these reasons we suggest that OATPs might be responsible not only for PFCs clearance and re-uptake, but also for the accumulation of these chemicals within important target tissues.
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